Twitter Beğeni Hilesi

📢 Our new summary paper on Pathway to Success in Cancer Treatment is live. This public working session at the European Parliament addresses the challenges and recommendations for achieving radioligand therapy readiness in Europe: bit.ly/4e6vBcE. #CancerResearch

IQVIA Institute’s 2024 Pre-ESMO Symposium is happening next week. Join us in-person in Barcelona or virtually for an essential discussion on strengthening Europe as a global center for oncology trials. Secure your spot: bit.ly/3Z87tlT. #Oncology

There's still time to register for IQVIA Institute's multi-stakeholder webinar on Rethinking Clinical Trial Country Prioritization on Monday, September 9th: short.url/aBcXyZ. #ClinicalTrials

📢 Rethinking Obesity: Impact on Healthcare Economics and Clinical Practice summarizes insights from our recent multi-stakeholder roundtable. Explore the transformative impact of anti-obesity medications: bit.ly/3Xxe9bZ. #Obesity

The healthcare landscape is rapidly evolving with 250-270 novel therapies expected by 2028 in specialized areas such as oncology and immunology. Join Murray Aitken, Executive Director of the IQVIA Institute, at Digital Pharma East: bit.ly/4eeVmrC. #DigitalPharmaEast

Patient organizations play a vital role in the U.S., particularly in areas such as rare diseases, oncology, childhood illnesses, and birth defects. Explore a comprehensive analysis of their impact: bit.ly/3XAbZbs. #PatientOutcomes

Are hematology drugs accessible to patients across Europe? Find out in the IQVIA Institute's report, Hematologic Cancer Opportunities for Patient Equality (HOPE). 🩸 Get the full insights: bit.ly/3B9iE3B. #Oncology #PharmaSpending

🔍 Exhibit 23 from the Strengthening Pathways for Cell and Gene Therapies report reveals that the majority of cell therapies and cell-based immunotherapies are autologous, requiring precise logistical coordination. 🧬 bit.ly/47CiRZD

Curious how illegal online pharmacies are detected? Here’s the step-by-step process: identify domains, scrape and classify data, iterate, and map out the IOP network. Dive into the full analysis: bit.ly/3XE3rAB.

Scaling up clinical research in Africa is not just a public health priority—it’s an economic and societal game-changer. The latest World Economic Forum article, featuring research from the IQVIA Institute, highlights how expanding trials can strengthen healthcare: bit.ly/3B24X6M.

Biosimilars are making their mark, with 11% of total biologic sales now facing competition and biosimilar efficiency hitting 24%. For a detailed breakdown, explore our report: bit.ly/4ejDJH3.

Join us on 9/17 for Hematologic Cancer Opportunities for Patient Equality, a critical discussion on ensuring equitable and timely access to hematological cancer therapies. 🌍Attend virtually or #WCC2024 attendees stop by CICG in Room 9 – level +2 bit.ly/3XEvrns.

Our insight brief captures highlights from the webinar, Patient Organization Research Collaborations. Read about evolving guidance from regulators and the growing synergy between patient organizations and life sciences: bit.ly/4ejhGQK.

🧬 The landscape of cell therapies is evolving rapidly. Our report on Strengthening Pathways for Cell and Gene Therapies reveals a significant rise in CAR T-cell products, reaching $4.5Bn in 2023: bit.ly/3ze1CAZ. #CellTherapy #GeneTherapy

Explore the advantages of a U.S.–India Medicine Partnership in IQVIA Institute's report. 🌍🤝 This alliance harnesses scale, technology, and expertise to strengthen and de-risk the U.S. pharmaceutical supply chain: bit.ly/4eocZoU.

IQVIA Institute's Pre-ESMO Symposium in Barcelona on Friday was a great success. Thank you to all of our expert speakers and attendees. If you missed it, you can watch the on-demand version here  bit.ly/4d7axlB

🧑‍🔬Experts came together on April 11 th , 2024, at the European Parliament to discuss recommendations to enhance radioligand therapy capacity in Europe. Download the full proceedings: bit.ly/4e362tG.

📢 Our latest summary paper, Pathway to Success in Cancer Treatment, is now available. This session at the European Parliament tackles the challenges and offers recommendations for ensuring radioligand therapy readiness across Europe: bit.ly/3MNvwz7. #CancerResearch

Join the IQVIA Institute for a special Health Policy Forum. Top health policy leaders from both sides of the political spectrum will discuss the key healthcare priorities shaping the 2024 U.S. presidential election. Register: bit.ly/3Xs4fr2. #HealthPolicy

🧬 IQVIA Institute recently hosted a multi-stakeholder panel to discuss key challenges, patient access, and what's next for the Cell and Gene Therapy sector. Access the webinar here: bit.ly/4gvDmLl